Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 02, 2023

SELL
$39.13 - $47.24 $11,739 - $14,172
-300 Reduced 2.03%
14,476 $586,000
Q2 2023

Aug 11, 2023

SELL
$43.93 - $46.76 $298,724 - $317,968
-6,800 Reduced 31.52%
14,776 $665,000
Q1 2023

May 02, 2023

BUY
$45.29 - $50.76 $307,972 - $345,168
6,800 Added 46.02%
21,576 $991,000
Q3 2022

Nov 07, 2022

SELL
$40.9 - $50.42 $81,800 - $100,840
-2,000 Reduced 11.92%
14,776 $610,000
Q1 2022

Apr 29, 2022

SELL
$42.23 - $54.3 $168,920 - $217,200
-4,000 Reduced 19.25%
16,776 $822,000
Q4 2021

Feb 03, 2022

BUY
$50.62 - $56.47 $156,922 - $175,057
3,100 Added 17.54%
20,776 $1.03 Million
Q3 2021

Oct 18, 2021

SELL
$46.55 - $56.83 $16,292 - $19,890
-350 Reduced 1.94%
17,676 $913,000
Q2 2021

Aug 06, 2021

SELL
$46.28 - $52.75 $598,169 - $681,793
-12,925 Reduced 41.76%
18,026 $872,000
Q4 2020

Jan 25, 2021

BUY
$46.09 - $54.74 $11,522 - $13,685
250 Added 0.81%
30,951 $1.64 Million
Q2 2020

Jul 27, 2020

SELL
$39.49 - $44.36 $709,042 - $796,483
-17,955 Reduced 36.9%
30,701 $1.31 Million
Q1 2020

Apr 17, 2020

BUY
$33.17 - $41.6 $208,971 - $262,080
6,300 Added 14.87%
48,656 $2.02 Million
Q4 2019

Jan 17, 2020

SELL
$25.41 - $43.1 $1.01 Million - $1.71 Million
-39,705 Reduced 48.38%
42,356 $1.43 Million
Q3 2019

Oct 17, 2019

BUY
$32.73 - $40.81 $517,003 - $644,634
15,796 Added 23.84%
82,061 $2.71 Million
Q1 2019

Apr 17, 2019

BUY
$33.78 - $40.68 $304,290 - $366,445
9,008 Added 15.73%
66,265 $2.7 Million
Q3 2018

Oct 16, 2018

BUY
$35.99 - $39.39 $1.29 Million - $1.41 Million
35,856 Added 167.54%
57,257 $2.17 Million
Q4 2017

Jan 12, 2018

BUY
$30.68 - $35.37 $260,780 - $300,645
8,500 Added 65.89%
21,401 $662,000
Q3 2017

Oct 13, 2017

BUY
$31.02 - $32.94 $400,189 - $424,958
12,901
12,901 $406,000

Others Institutions Holding QGEN

About QIAGEN N.V.


  • Ticker QGEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 227,694,000
  • Market Cap $9.92B
  • Description
  • QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...
More about QGEN
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.